Payments to Acquire Property, Plant, and Equipment of Stoke Therapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Stoke Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Stoke Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $152,000, a 1167% increase year-over-year.
  • Stoke Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $670,000, a 230% increase from 2024.
  • Stoke Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $203,000, a 87% decline from 2023.
  • Stoke Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,616,000, a 59% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Stoke Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $670,000 +$467,000 +230% 01 Jan 2025 31 Dec 2025 10-K 16 Mar 2026 2025 FY
2024 $203,000 -$1,413,000 -87% 01 Jan 2024 31 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $1,616,000 -$2,346,000 -59% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025 2024 FY
2022 $3,962,000 +$2,762,000 +230% 01 Jan 2022 31 Dec 2022 10-K 25 Mar 2024 2023 FY
2021 $1,200,000 +$150,000 +14% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $1,050,000 -$585,000 -36% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022 2021 FY
2019 $1,635,000 +$700,000 +75% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $935,000 01 Jan 2018 31 Dec 2018 10-K 23 Mar 2020 2019 FY

Stoke Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $152,000 +$140,000 +1167% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $12,000 -$153,000 -93% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $165,000 -$676,000 -80% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $841,000 +$637,000 +312% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $204,000 -$406,000 -67% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $610,000 +$518,000 +563% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $92,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.